Kansikuva näyttelystä The New GLP-1 Pill — No More Injections?

The New GLP-1 Pill — No More Injections?

Podcast by Inception Point AI

englanti

Terveys & hyvinvointi

14 vrk ilmainen kokeilu

Kokeilun jälkeen 7,99 € / kuukausi.Peru milloin tahansa.

  • Podimon podcastit
  • Lataa offline-käyttöön
Aloita maksutta

Lisää The New GLP-1 Pill — No More Injections?

Oral GLP-1 medications promise weight-loss results without needles, but can a daily pill with minimal absorption truly rival the proven power of weekly injections? Host Julia Cartwright unpacks the science, compares real-world trade-offs, and explores how new pricing models could finally make these drugs accessible to millions. For more content like this, visit QuietPlease.ai This content was created in partnership and with the help of Artificial Intelligence AI.

Kaikki jaksot

8 jaksot

jakson The New GLP-1 Pill — No More Injections? - Unpack the science changing weight loss forever with Julia Cartwright kansikuva

The New GLP-1 Pill — No More Injections? - Unpack the science changing weight loss forever with Julia Cartwright

Join host Julia Cartwright as she explores the groundbreaking shift from GLP-1 injections to pills for weight loss. Discover how these oral medications work, their effectiveness versus shots, and what this needle-free option means for accessibility and cost. Perfect for anyone curious about weight management's future. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7. huhti 2026 - 32 s
jakson The New GLP-1 Pill — No More Injections? - Can a Daily Tablet Replace Your Weekly Injection? kansikuva

The New GLP-1 Pill — No More Injections? - Can a Daily Tablet Replace Your Weekly Injection?

Join AI host Julia Cartwright as she compares Foundayo, the FDA-approved daily GLP-1 pill, with injectable Wegovy. We examine clinical trial data showing Foundayo's 12.4% weight loss versus Wegovy's 15-16%, discuss medication adherence challenges, switching protocols, and explore who benefits most from each option in this evolving weight management landscape. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7. huhti 2026 - 25 min
jakson The New GLP-1 Pill — No More Injections? - $25 a Month and the Access Revolution kansikuva

The New GLP-1 Pill — No More Injections? - $25 a Month and the Access Revolution

Julia Cartwright explores how oral GLP-1 medications transformed obesity treatment access in 2026. Oral Wegovy and Foundayo launched at $25-$149 monthly, eliminating needles and cost barriers that kept 90% of eligible patients untreated. With 170,000 prescriptions in three weeks and home delivery options, the access revolution began reshaping healthcare for millions. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7. huhti 2026 - 30 min
jakson The New GLP-1 Pill — No More Injections? - Needle-Free at Last, But Who Is This For? kansikuva

The New GLP-1 Pill — No More Injections? - Needle-Free at Last, But Who Is This For?

Julia Cartwright explores Foundayo, the FDA-approved daily GLP-1 pill that offers a needle-free alternative for weight management. She examines who truly benefits from this $149/month medication—addressing barriers of cost, needle aversion, and accessibility that keep 90% of eligible patients untreated, while honestly comparing its effectiveness to injectable options. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7. huhti 2026 - 27 min
Loistava design ja vihdoin on helppo löytää podcasteja, joista oikeasti tykkää
Loistava design ja vihdoin on helppo löytää podcasteja, joista oikeasti tykkää
Kiva sovellus podcastien kuunteluun, ja sisältö on monipuolista ja kiinnostavaa
Todella kiva äppi, helppo käyttää ja paljon podcasteja, joita en tiennyt ennestään.

Valitse tilauksesi

Suosituimmat

Premium

  • Podimon podcastit

  • Ei mainoksia Podimon podcasteissa

  • Peru milloin tahansa

14 vrk ilmainen kokeilu
Sitten 7,99 € / kuukausi

Aloita maksutta

Premium

20 tuntia äänikirjoja

  • Podimon podcastit

  • Ei mainoksia Podimon podcasteissa

  • Peru milloin tahansa

14 vrk ilmainen kokeilu
Sitten 9,99 € / kuukausi

Aloita maksutta

Premium

100 tuntia äänikirjoja

  • Podimon podcastit

  • Ei mainoksia Podimon podcasteissa

  • Peru milloin tahansa

14 vrk ilmainen kokeilu
Sitten 19,99 € / kuukausi

Aloita maksutta

Vain Podimossa

Suosittuja äänikirjoja

Usein kysytyt kysymykset

Lisää kysymyksiä & vastauksia
Aloita maksutta

14 vrk ilmainen kokeilu. Kokeilun jälkeen 7,99 € / kuukausi. Peru milloin tahansa.